Jazz Pharmaceuticals Announces U.S. FDA Acceptance for Filing with Priority Review of NDA for Defibrotide for Hepatic Veno-Occlusive Disease by longitudeadmin | Sep 30, 2015 | Portfolio News
CardioDx Announces Positive Data from a Large Primary Care Registry on the Impact of the Corus CAD Test in the Assessment of Obstructive Coronary Artery Disease in Women by longitudeadmin | Sep 30, 2015 | Portfolio News
CardioDx Announces Positive Data from a Large Primary Care Registry on the Impact of the Corus CAD Test in the Assessment of Obstructive Coronary Artery Disease in Women by longitudeadmin | Sep 28, 2015 | Portfolio News
Corcept Therapeutics Appoints Robert S. Fishman, M.D., as Chief Medical Officer by longitudeadmin | Sep 28, 2015 | Portfolio News
Esperion Therapeutics Provides Further Updates on ETC-1002 Global Phase 3 Strategy Following Receipt of End-of-Phase 2 Meeting Minutes by longitudeadmin | Sep 28, 2015 | Portfolio News
